Zobrazeno 1 - 10
of 40
pro vyhledávání: '"Kishore Narayanan"'
Autor:
Yuki Nakamura, PhD, Takeo Urakami, PhD, Kayoko Ishimaru, Nguyen Quoc Vuong Tran, PhD, Takafumi Shimizu, MS, William Sinko, PhD, Taisuke Takahashi, PhD, Sivapriya Marappan, PhD, Kishore Narayanan, PhD, Ramulu Poddutoori, PhD, Yoh Terada, PhD, Atsuhito Nakao, MD, PhD
Publikováno v:
Journal of Allergy and Clinical Immunology: Global, Vol 3, Iss 3, Pp 100249- (2024)
Background: The KIT receptor tyrosine kinase and its ligand, stem cell factor (SCF), control proliferation and survival of mast cells. Thus, targeting KIT signaling may show promise for the treatment of allergic diseases involving mast cells. Recentl
Externí odkaz:
https://doaj.org/article/1994ab6df89d4c908673e9912bac564f
Publikováno v:
Student's Journal of Health Research Africa, Vol 4, Iss 9 (2023)
Aim: This study is an attempt to perform an analysis about the clinical profile, serological indicators and predictors of dengue in children. Materials And Methods: The study was conducted including paediatric dengue admissions into a tertiary care
Externí odkaz:
https://doaj.org/article/9afe04f70b5b430b898683dee9cd61ff
Autor:
Pekka J. Kallio, Murali Ramachandra, Nanduri Srinivas, Ravi K. Ujjinamatada, Subhendu Mukherjee, Samiulla Dhodheri, Thomas Anthony, Nagaraj Gowda, Rashmi Nair, Jiju Mani, Raghuveer K. Ramachandra, Kishore Narayanan, Shekar Chelur, Srinivasan Rajagopalan, Susanta Samajdar, Timo Korjamo, Riikka Oksala, Stefan Karlsson, Gerd Wohlfahrt, Tero Linnanen, Mari L. Björkman, Tarja Ikonen, Anu-Maarit Moilanen, Tim H. Holmström
Supplementary table S1 shows the effect of ODM-203 in a large kinase panel. Supplementary figure S1 shows how ODM-203 is synthesized. Supplementary figure S2 shows the effect of ODM-203 on FRS2 phosphorylation. Supplement figure S3 shows the effect o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01a4b40ece62b019671a48c99c70cd8b
https://doi.org/10.1158/1535-7163.22505722
https://doi.org/10.1158/1535-7163.22505722
Autor:
Pekka J. Kallio, Murali Ramachandra, Nanduri Srinivas, Ravi K. Ujjinamatada, Subhendu Mukherjee, Samiulla Dhodheri, Thomas Anthony, Nagaraj Gowda, Rashmi Nair, Jiju Mani, Raghuveer K. Ramachandra, Kishore Narayanan, Shekar Chelur, Srinivasan Rajagopalan, Susanta Samajdar, Timo Korjamo, Riikka Oksala, Stefan Karlsson, Gerd Wohlfahrt, Tero Linnanen, Mari L. Björkman, Tarja Ikonen, Anu-Maarit Moilanen, Tim H. Holmström
Alterations in the gene encoding for the FGFR and upregulation of the VEGFR are found often in cancer, which correlate with disease progression and unfavorable survival. In addition, FGFR and VEGFR signaling synergistically promote tumor angiogenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b0ba784729eaeca665669c7e27a87040
https://doi.org/10.1158/1535-7163.c.6538162.v1
https://doi.org/10.1158/1535-7163.c.6538162.v1
Autor:
Ramulu Poddutoori, Kimberly Aardalen, Kiran Aithal, Sanjeev Surendranath Barahagar, Charamanna Belliappa, Mark Bock, Shekar Chelur, Andrea Gerken, Sreevalsam Gopinath, Bjoern Gruenenfelder, Michael Kiffe, Maithreyi Krishnaswami, John Langowski, Sudharshan Madapa, Kishore Narayanan, Chetan Pandit, Sunil Kumar Panigrahi, Mark Perrone, Ravi Kumar Potakamuri, Murali Ramachandra, Anuradha Ramanathan, Rita Ramos, Emine Sager, Susanta Samajdar, Hosahalli S. Subramanya, Devaraja Seethappa Thimmasandra, Eleni Venetsanakos, Henrik Möbitz
Publikováno v:
Journal of Medicinal Chemistry. 65:4350-4366
Mutations in MEK1/2 have been described as a resistance mechanism to BRAF/MEK inhibitor treatment. We report the discovery of a novel ATP-competitive MEK1/2 inhibitor with efficacy in wildtype (WT) and mutant MEK12 models. Starting from a HTS hit, we
Publikováno v:
Journal of School and University Medicine. :14-21
Introduction: The current pandemic has affected the education of children in an unprecedented way. Children are not able to go to school and in a short span of time schools have tried to come up with online teaching methods which have not been valida
Autor:
Takeo Urakami, Taisuke Takahashi, Takafumi Shimizu, William Sinko, Yuki Nakamura, Kayoko Ishimaru, Vuong Tran, Ramulu Poddutoori, Kishore Narayanan, Sivapriya Marappan, Atsuhito Nakao, Yoh Terada
Publikováno v:
Journal of Allergy and Clinical Immunology. 151:AB204
Autor:
Girish Daginakkatte, Kavitha Nellore, Sunil Kumar Panigrahi, Sagar dadhania, AB Aravind, Thomas Antony, Megha Goyal, Murali Ramachandra, DS Samiulla, Prasath Kothandaraman, Susanta Samajdar, Dinesh Chikkanna, Rashmi Nair, Kishore Narayanan, Chandregowda Venkateshappa, Garima Priyadarshani, Vijay Kamal Ahuja
Publikováno v:
Cancer Research. 81:1713-1713
CD73 is a cell surface ectoenzyme, which is overexpressed in many types of human and mouse cancers. CD73 is the primary enzymatic producer of immunosuppressive adenosine in the tumor microenvironment, and high CD73 expression is associated with signi
Autor:
Shahadat Ahmed, Kishore Narayanan, Chetan Pandit, Mukherjee, Subhendu, Amol V. Gadakh, Sivapriya Marappan, Samiulla Syed Dodheri, Surendranath, Sanjeev Barahagar, Sushmita, Ratna, O, Krishna Mohan, Avula Rajasekhar, Sammeta Srinivasa Raju, Vasantha Kumar G, Dastagiri B, Ganipisetty, Srinivasa RAO, N Kasieswara, S, Vijaya Shekar, S Jagan Mohan Reddy, Chikkanna, Dinesh, Murali Ramachandra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::555da876449a0949253277abea1f6b50
Autor:
Shekar Chelur, Murali Ramachandra, Samiulla Dhodheri, Stefan Karlsson, Nanduri Srinivas, Thomas Anthony, Nagaraj Gowda, Kishore Narayanan, Tero Linnanen, Raghuveer Ramachandra, Tarja Ikonen, Jiju Mani, Susanta Samajdar, Ravi Kotrabasaiah Ujjinamatada, Srinivasan Rajagopalan, Timo Korjamo, Mari Björkman, Subhendu Mukherjee, Pekka Kallio, Rashmi Nair, Riikka Oksala, Gerd Wohlfahrt, Tim H. Holmström, Anu-Maarit Moilanen
Publikováno v:
Molecular cancer therapeutics. 18(1)
Alterations in the gene encoding for the FGFR and upregulation of the VEGFR are found often in cancer, which correlate with disease progression and unfavorable survival. In addition, FGFR and VEGFR signaling synergistically promote tumor angiogenesis